Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation

Oncogenesis - United States
doi 10.1038/oncsis.2017.36
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells

PLoS ONE
Multidisciplinary
2015English

Prohibitins Role in Cellular Survival Through Ras-Raf-Mek-Erk Pathway

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2014English

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2006English

MicroRNA‑98 Suppresses Cell Growth and Invasion of Retinoblastoma via Targeting the IGF1R/k‑Ras/Raf/MEK/ERK Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2019English

MicroRNA‑143‑3p Suppresses Cell Growth and Invasion in Laryngeal Squamous Cell Carcinoma via Targeting the K‑Ras/Raf/Mek/Erk Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

The Intermediate-Activity L597VBRAF Mutant Acts as an Epistatic Modifier of Oncogenic RAS by Enhancing Signaling Through the RAF/MEK/ERK Pathway

Genes and Development
GeneticsDevelopmental Biology
2012English

Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway

Cancer Management and Research
Oncology
2020English

Epigallocatechin-3-Gallate Inhibits the Growth and Increases the Apoptosis of Human Thyroid Carcinoma Cells Through Suppression of EGFR/RAS/RAF/MEK/ERK Signaling Pathway

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy